Frankel Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.80 M
as on 07-12-2024
- Revenue -59.80%
(FY 2022)
- Profit -68.57%
(FY 2022)
- Ebitda -37.30%
(FY 2022)
- Net Worth -13.97%
(FY 2022)
- Total Assets -48.52%
(FY 2022)
About Frankel Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.80 M.
Hardik Upadhayay and Purnima Kirit serve as directors at the Company.
- CIN/LLPIN
U74999MH2017PTC291689
- Company No.
291689
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Frankel Healthcare Private Limited offer?
Frankel Healthcare Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmacy Dropshipper, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Anti Infective Drugs & Medicines, HIV Drugs, Antiviral Drugs, Common Disease Medicines, Pharmaceutical Capsules, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Frankel Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hardik Upadhayay  | Director | 27-Feb-2017 | Current |
| Purnima Kirit | Director | 30-Dec-2018 | Current |
Financial Performance of Frankel Healthcare.
Frankel Healthcare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 59.8% decrease. The company also saw a substantial fall in profitability, with a 68.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Frankel Healthcare?
In 2020, Frankel Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Apr 2019 | ₹1.80 M | Open |
How Many Employees Work at Frankel Healthcare?
Unlock and access historical data on people associated with Frankel Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Frankel Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Frankel Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
